Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia

New England Journal of Medicine

Volumn 369, Issue 22, 2013, Pages 2115-2125

  Louiset, Estelle ^a   Duparc, Céline ^a   Young, Jacques ^b   Renouf, Sylvie ^a   Nomigni, Milène Tetsi ^a   Boutelet, Isabelle ^a   Libé, Rossella ^c   Bram, Zakariae ^a   Groussin, Lionel ^c,d,e,f   Caron, Philippe ^h   Tabarin, Antoine ⁱ   Grunenberger, Fabienne ^j   Christin Maitre, Sophie ^g   Bertagna, Xavier ^c,d,e,f   Kuhn, Jean Marc ^a,k   Anouar, Youssef ^a   Bertherat, Jérôme ^c,d,e,f   Lefebvre, Hervé ^a,k  

^a UNIVERSITÉ DE ROUEN   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSTITUT COCHIN   (France)

^d Hôpital Cochin ^*  (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CNRS   (France)

^g HÔPITAL SAINT ANTOINE   (France)

^h SERVICE DE PNEUMOLOGIE   (France)

ⁱ HAUT LÉVÊQUE HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^k ROUEN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RECEPTOR; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE; LIGAND; MEMBRANE RECEPTOR; MESSENGER RNA; PEPTIDE HORMONE RECEPTOR BLOCKING AGENT; PROOPIOMELANOCORTIN; GASTRIC INHIBITORY POLYPEPTIDE;

ADRENAL GLAND; ADRENAL HYPERPLASIA; ADULT; AGED; ARTICLE; BILATERAL MACRONODULAR ADRENAL HYPERPLASIA; BLOOD SAMPLING; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; EXPLANT; FEMALE; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROIDOGENESIS; VENOUS BLOOD; BIOSYNTHESIS; BLOOD; CUSHING SYNDROME; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS);

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CUSHING SYNDROME; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PRO-OPIOMELANOCORTIN; RNA, MESSENGER;

EID: 84888351647     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1215245     Document Type: Article

References (36)

1. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006;367:1605-17.
2. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-34.
3. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 1992;327:981-6.
4. Lacroix A, Bolté E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med 1992;327:974-80.
5. Mune T, Murase H, Yamakita N, et al. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 2002;87:5706-13.
6. De Groot JWB, Links TP, Themmen APN, et al. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome. Eur J Endocrinol 2010;163:293-9.
7. Bertherat J, Contesse V, Louiset E, et al. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 2005;90:1302-10.
8. Louiset E, Contesse V, Groussin L, et al. Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 2006;91:4578-86.
9. Cartier D, Lihrmann I, Parmentier F, et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 2003;88:248-54.
10. Assie G, Louiset E, Sturm N, et al. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome. J Clin Endocrinol Metab 2010;95:E253-E262.
11. Swords FM, Baig A, Malchoff DM, et al. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Mol Endocrinol 2002;16:2746-53.
12. Fragoso MC, Domenice S, Latronico AC, et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003;88:2147-51.
13. Vezzosi D, Libé R, Baudry C, et al. Phosphodiesterase 11A (PDE11A) gene defects in patients with ACTH-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors. J Clin Endocrinol Metab 2012;97:E2063-E2069.
14. Lefebvre H, Duparc C, Chartrel N, et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 2003;88:3035-42.
15. Mazzuco TL, Thomas M, Martinie M, et al. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker- sensitive Cushing's syndrome. Arq Bras Endocrinol Metabol 2007;51:1452-62.
16. Iwata M, Oki Y, Okazawa T, et al. A rare case of adrenocorticotropic hormone (ACTH)-independent macroadrenal hyperplasia showing ectopic production of ACTH. Intern Med 2012;51:2181-7.
17. Hiroi N, Chrousos GP, Kohn B, et al. Adrenocortical-pituitary hybrid tumor causing Cushing's syndrome. J Clin Endocrinol Metab 2001;86:2631-7.
18. Libé R, Fratticci A, Coste J, et al. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res 2008;14:4016-24.
19. Vezzosi D, Cartier D, Régnier C, et al. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol 2007;156:21-31.
20. Lamolet B, Pulichino AM, Lamonerie T, et al. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001;104:849-59.
21. Vallette-Kasic S, Figarella-Branger D, Grino M, et al. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 2003;88:3050-6.
22. Suda T, Tomori N, Tozawa F, et al. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer, and pheochromocytoma. J Clin Endocrinol Metab 1984;58:919-24.
23. Meyer WJ III, Smith EM, Richards GE, Cavallo A, Morrill AC, Blalock JE. In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-deficient individuals. J Clin Endocrinol Metab 1987;64:98-105.
24. Parker KL, Schimmer BP. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev 1997;18:361-77.
25. Connelly MA. SR-BI-mediated HDL cholesteryl ester delivery in the adrenal gland. Mol Cell Endocrinol 2009;300:83-8.
26. Marx C, Bornstein SR, Wolkersdörfer GW, Peter M, Sippell WG, Scherbaum WA. Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex. J Clin Endocrinol Metab 1997;82:3136-40.
27. Ivell R, Balvers M, Domagalski R, Ungefroren H, Hunt N, Schulze W. Relaxin-like factor: a highly specific and constitutive new marker for Leydig cells in the human testis. Mol Hum Reprod 1997;3:459-66.
28. de Keyzer Y, Lenne F, Massias JF, et al. Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors. J Clin Invest 1990;86:871-7.
29. Lacaze-Masmonteil T, de Keyzer Y, Luton JP, Kahn A, Bertagna X. Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc Natl Acad Sci U S A 1987;84:7261-5.
30. Claahsen-van der Grinten HL, Hermus ARMM, Otten BJ. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2009;23:209-20.
31. Hsiao H-P, Kirschner LS, Bourdeau I, et al. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab 2009;94:2930-7.
32. Swain JM, Grant CS, Schlinkert RT, et al. Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Arch Surg 1998;133:541-5.
33. van Aken MO, Pereira AM, Van Thiel SW, et al. Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome. J Clin Endocrinol Metab 2005;90:1570-7.
34. Kalsbeek A, van der Spek R, Lei J, Endert E, Buijs RM, Fliers E. Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Mol Cell Endocrinol 2012;349:20-9.
35. Thomas M, Keramidas M, Monchaux E, Feige J-J. Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex. Endocrinology 2004;145:4320-9.
36. Stratakis CA, Boikos SA. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab 2007;3:748-57.